Click on a filter below to refine your search. Remove a filter to broaden your search.
Significant reductions were seen in risks for atrial fibrillation, stroke with guideline-adherent physical activity assessed with an accelerometer.
Sacubitril-valsartan is not linked to a reduced incidence of death from cardiovascular causes or incident heart failure versus ramipril.
Federal health officials are waiting on results from a government-backed clinical trial and from studies by Johnson & Johnson
No benefit was seen versus valsartan for reducing NT-proBNP levels for patients with chronic advanced heart failure and reduced ejection fraction.
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
After full adjustment, an association between influenza vaccination and ischemic stroke yielded an adjusted odds ratio of 0.88.
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
The vaccine advisory panel for the CDC is set to meet Thursday and Friday to discuss who should get the updated boosters.
As of July 14, 1,470 cases of monkeypox have been identified in 44 jurisdictions in the United States.
And patients on maintenance dialysis who received COVID-19 vaccination had decreasing antibody titers over time.